American Society of Hirudotherapy

Construction of a coagulation prediction model of the extracorporeal circulation circuit during hemodialysis with regional citrate anticoagulant (RCA)

Research article published in The International journal of artificial organs (2024)

Last Updated: November 1, 2026ASH Editorial · based on the books
Research article — evidence review: Off-label use means application outside the FDA-cleared indication. Clinical evidence (RCTs or systematic reviews) supports this use, but the FDA has not cleared it.Article reference: Content describes science, methodology, or organizational reference material — not a clinical efficacy claim.
Evidence: Research reportClinical LiteratureGong et al. · The International journal of artificial organs, 2024

Abstract

OBJECTIVE: To construct a prediction model of coagulation in the extracorporeal circulation circuit during hemodialysis with regional citrate anticoagulant(RCA) conditions. METHODS: This was a single-center, retrospective study. The clinical data of patients who received hemodialysis with RCA from February 2021 to March 2022 were collected. The risk predictors of coagulation in the extracorporeal circulation circuit were screened by LASSO regression. On this basis, we used multivariate logistic regression analysis to establish a nomogram prediction model. RESULTS: A total of 98 patients received RCA hemodialysis for 362 times. Among them, 155 treatments with complete data were included in the study. Among the 155 treatments, coagulation of the extracorporeal circulation circuit occurred 12 times. The use of arteriovenous fistulas(AVF), the venous pressure at 4 h after hemodialysis initiation, blood flow velocity, dialyzer manufacturer, Systemic iCa2+ at 1 h after hemodialysis initiation, plasma albumin level, and plasma d-dimer level were influencing factors of coagulation in the extracorporeal circuit during hemodialysis with RCA (p < 0.05). A nomogram model was made out of the above indicators. The area under the receiver operating characteristic (ROC) curve for predicting coagulation in the circuit was 0.967 (95% CI: 0.935-0.998). The internal validation result of the memory testing (bootstrap method) showed that the area under the ROC curve was 0.967 (95% CI: 0.918-0.991). CONCLUSION: The nomogram model has good discrimination and calibration and can intuitively and succinctly predict the risk of coagulation in the extracorporeal circulation circuit during hemodialysis with RCA.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeJournal Article
Indexed MeSH termsHumansRenal DialysisExtracorporeal CirculationFemaleMaleMiddle AgedRetrospective StudiesAnticoagulantsBlood CoagulationNomogramsAgedCitric AcidAdult

Summary

A retrospective single-center study of 155 regional citrate anticoagulant hemodialysis treatments derived a nomogram from seven factors, including venous pressure, blood flow velocity, and plasma albumin, achieving an AUC of 0.967 for predicting extracorporeal circuit coagulation.

Why This Matters for Hirudotherapy

This single-center retrospective study used LASSO and multivariate logistic regression to build a nomogram predicting clotting of the extracorporeal circuit during hemodialysis under regional citrate anticoagulation, drawing on 155 completed treatments (in which circuit coagulation occurred 12 times) and identifying factors such as access type, post-initiation venous pressure, blood-flow velocity, dialyzer, ionized calcium, albumin, and d-dimer, with a reported area under the ROC curve of 0.967. Its relevance to hirudotherapy is contextual rather than direct: it illustrates the persistent clinical problem of controlling extracorporeal and local clotting, the same coagulation biology that the leech's hirudin and other salivary anticoagulants act upon, and reinforces why robust anticoagulant strategies remain a research priority. Honest caveat: this is a small, single-center retrospective predictive-modeling study with only 12 outcome events and internal validation only; it involves no leech product and the high AUC has not been externally validated, so it should not be read as evidence about hirudotherapy.

Citation

Reference (Vancouver style)

Gong Y, Zou M, Luo L. Construction of a coagulation prediction model of the extracorporeal circulation circuit during hemodialysis with regional citrate anticoagulant (RCA). Int J Artif Organs. 2024;47(10):749-755. doi:10.1177/03913988241269524. PMID: 39171444

Bibliographic details (authors, volume, pages, DOI) are taken from the PubMed record.

Added to ASH library: May 28, 2026 · Site last updated: November 1, 2026

This website provides educational information and does not constitute medical advice, diagnosis, or treatment recommendations. Medicinal leech therapy carries clinically meaningful risks and should be performed only by qualified clinicians under institutionally approved protocols. FDA 510(k) clearance for medicinal leeches is limited to specific indications; investigational and off-label discussions are labeled accordingly. For patient-specific guidance, consult a qualified healthcare provider.